Chordomas of the craniospinal axis: Multimodality surgical, radiation and medical management strategies

Kenji Muro*, Sunit Das, Jeffrey J. Raizer

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations

Abstract

Chordomas are neoplasms of the primitive notochord remnants and are characterized by slow growth kinetics, locally aggressive behavior and resistance to conventional therapeutic options. They are found primarily in the skull base or the sacral region, although they can occur anywhere in the craniospinal axis. If an oncologic surgical resection can be performed safely, patients derive the maximal benefit. Adjuvant radiotherapy has a proven benefit in both progression-free and overall survival. Chemotherapy plays a limited role and currently remains an option at tumor recurrence, although increasing knowledge of the molecular biology of chordomas may lead to targeted therapeutic strategies. In this review, the current multimodality treatment strategy for chordomas will be discussed and future directions will be highlighted.

Original languageEnglish (US)
Pages (from-to)1295-1312
Number of pages18
JournalExpert Review of Neurotherapeutics
Volume7
Issue number10
DOIs
StatePublished - Oct 1 2007

Keywords

  • Chemotherapy
  • Chordoma
  • Radiation
  • Sacral
  • Skull base

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Chordomas of the craniospinal axis: Multimodality surgical, radiation and medical management strategies'. Together they form a unique fingerprint.

Cite this